The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
As of April 2025 Amgen has a market cap of C$208.89 Billion. This makes Amgen the world's 98th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | C$208.89 B | 3.11% |
2024 | C$202.59 B | -0.91% |
2023 | C$204.44 B | 7.51% |
2022 | C$190.16 B | 17.75% |
2021 | C$161.49 B | -5.38% |
2020 | C$170.67 B | -8.34% |
2019 | C$186.20 B | 11.53% |
2018 | C$166.95 B | 5.2% |
2017 | C$158.71 B | 8.58% |
2016 | C$146.16 B | -13.91% |
2015 | C$169.78 B | 20.79% |
2014 | C$140.56 B | 53.39% |
2013 | C$91.63 B | 41.35% |
2012 | C$64.82 B | 13.23% |
2011 | C$57.25 B | 11.94% |
2010 | C$51.14 B | -13.64% |
2009 | C$59.22 B | -19.44% |
2008 | C$73.51 B | 45.99% |
2007 | C$50.35 B | -45.7% |
2006 | C$92.73 B | -17.48% |
2005 | C$112.37 B | 15.75% |
2004 | C$97.08 B | -5.65% |
2003 | C$102.89 B | 4.55% |
2002 | C$98.42 B | 4.67% |
2001 | C$94.02 B | -5.38% |
2000 | C$99.37 B | 12.7% |
1999 | C$88.17 B | 115.43% |
1998 | C$40.93 B | 104.9% |
1997 | C$19.97 B | 1.33% |
1996 | C$19.71 B |
On Apr 24th, 2025 the market cap of Amgen was reported to be: